Towards a better mucolytic

Burton F. Dickey; Christopher M. Evans

doi:10.1183/13993003.00619-2023

Towards a better mucolytic

Burton F. Dickey, Christopher M. Evans

Pulmonary Medicine

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Article number	2300619
Journal	The European respiratory journal
Volume	61
Issue number	5
DOIs	https://doi.org/10.1183/13993003.00619-2023
State	Published - May 1 2023

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/13993003.00619-2023

Cite this

@article{e2a9c8d99a834727877386106fddcfb2,

title = "Towards a better mucolytic",

author = "Dickey, {Burton F.} and Evans, {Christopher M.}",

note = "Funding Information: Support statement: This work was supported by grants R01 HL129795 (to B.F. Dickey) and HL08039 (to C.M. Evans) from the US National Institutes of Health. Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: B.F. Dickey reports funding from NIH, NHLBI to study airway mucus dysfunction, and consulting fees from Arrowhead Pharmaceuticals on the treatment of muco-obstructive lung diseases. C.M. Evans reports funding from NIH, NHLBI to study airway mucus dysfunction.",

year = "2023",

month = may,

day = "1",

doi = "10.1183/13993003.00619-2023",

language = "English (US)",

volume = "61",

journal = "The European respiratory journal",

issn = "0903-1936",

number = "5",

}

TY - JOUR

T1 - Towards a better mucolytic

AU - Dickey, Burton F.

AU - Evans, Christopher M.

N1 - Funding Information: Support statement: This work was supported by grants R01 HL129795 (to B.F. Dickey) and HL08039 (to C.M. Evans) from the US National Institutes of Health. Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: B.F. Dickey reports funding from NIH, NHLBI to study airway mucus dysfunction, and consulting fees from Arrowhead Pharmaceuticals on the treatment of muco-obstructive lung diseases. C.M. Evans reports funding from NIH, NHLBI to study airway mucus dysfunction.

PY - 2023/5/1

Y1 - 2023/5/1

UR - http://www.scopus.com/inward/record.url?scp=85160458272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160458272&partnerID=8YFLogxK

U2 - 10.1183/13993003.00619-2023

DO - 10.1183/13993003.00619-2023

M3 - Editorial

C2 - 37230504

AN - SCOPUS:85160458272

SN - 0903-1936

VL - 61

JO - The European respiratory journal

JF - The European respiratory journal

IS - 5

M1 - 2300619

ER -

Towards a better mucolytic

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this